TipRanks
Go Ultimate55% OFF

Matthew Strobeck Insider Profile

11 Followers

Matthew Strobeck, Director at QuidelOrtho, holds 89.38K shares in QuidelOrtho (Ticker: QDEL), holds 5.76M shares in Biodesix (Ticker: BDSX), holds 325.24K shares in Accelerate Diagnostics (Ticker: AXDXQ).

Matthew Strobeck's Trading History

QDEL
QuidelOrtho
Jun 02, 2026DirectorUninformative Buy―$1.18M
BDSX
Biodesix
Nov 06, 2024DirectorInformative Buy55.60K$133.86M
AXDXQ
Accelerate Diagnostics
Jan 25, 2024―Uninformative Buy―$3.25K
YTENQ
Yield10 Bioscience
Jan 28, 2016DirectorUninformative Sell――
SNTS
Santarus
Apr 10, 2012―Uninformative Buy――

You May Also Like

Matthew Strobeck insider profile FAQ

What is the percentage of profitable transactions made by Matthew Strobeck?
The percentage of profitable transactions made by Matthew Strobeck is 50%.
What is the average return per transaction made by Matthew Strobeck?
The average return per transaction made by Matthew Strobeck is -7.30%.
What stocks does Matthew Strobeck hold?
Matthew Strobeck holds: QDEL, YTENQ, AXDXQ, BDSX, SNTS stocks.
What was Matthew Strobeck's most profitable transaction?
Matthew Strobeck’s most profitable transaction was an Informative Buy of AXDXQ stock on March 20, 2020. The return on the trade was 101.00%.
What is Matthew Strobeck's role in QuidelOrtho?
Matthew Strobeck's role in QuidelOrtho is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.